With high FDR associated with the predictors selected for preterm and term preeclampsia, we restricted the final predictor selection for modelling to these predictors which showed performances when assessed for all preeclampsia prediction, i.e., the biometric predictors MAP and BMI and the biomarkers PlGF, DLG and 1-HGP. The gene discussed is PGF; the disease is preeclampsia.